Consolidated Balance Sheets - USD ($)	Mar. 31, 2025	Dec. 31, 2024
CURRENT ASSETS
Cash and cash equivalents	$ 6,933	$ 1,763
Total current assets	6,933	1,763
TOTAL ASSETS	6,933	1,763
CURRENT LIABILITIES
Accounts payable and accrued expenses	3,676,722	3,549,339
Other liabilities	207,938	207,938
Notes payable, net	2,881,941	2,805,253
Convertible debt	125,000	125,000
Total current liabilities	6,891,601	6,687,530
Notes payable - other	12,507	12,625
TOTAL LIABILITIES	6,904,108	6,700,155
STOCKHOLDERS’ EQUITY
Common stock, $0.001 par value; 19,000,000,000 shares authorized 3,430,546,521 and 3,032,746,878 shares issued and outstanding, respectively	3,430,545	3,032,746
Additional paid-in-capital	43,690,323	43,675,323
Accumulated deficit	(54,018,043)	(53,406,461)
TOTAL STOCKHOLDERS’ DEFICIT	(6,897,175)	(6,698,392)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	6,933	1,763
Series A Preferred Stock [Member]
STOCKHOLDERS’ EQUITY
Preferred A voting stock, $0.001 par value; 10 shares authorized, 10 and -0- shares issued and outstanding, respectively as of March 31, 2025 and December 31, 2024

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.